Top Gainers for 10-26-22: $EPIX $GOVX $RNAZ

in topgainers •  2 years ago 

Top Gainers_2022.10.26.jpeg

$EPIX - Updated Results from the Phase 1/2 Study of ESSA's Lead Candidate EPI-7386 in Combination with Enzalutamide Highlighted at the 29th Annual Prostate Cancer Foundation Scientific Retreat: https://finance.yahoo.com/news/updated-results-phase-1-2-110000290.html

$GOVX - GeoVax to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 9, 2022: https://finance.yahoo.com/news/geovax-host-third-quarter-2022-130000845.html

$RNAZ - TransCode Therapeutics Reports Positive Preclinical Results with its Lead Candidate, TTX-MC138, in Pancreatic Adenocarcinoma: https://finance.yahoo.com/news/transcode-therapeutics-reports-positive-preclinical-110000803.html

topgainers epix govx rnaz
2 years ago by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
    0
    Authors get paid when people like you upvote their post.
    If you enjoyed what you read here, create your account today and start earning FREE STEEM!